TABLE-Valeant more than halves Q4 net loss

Feb 28 (Reuters) -

VALEANT PHARMACEUTICALS INTERNATIONAL INC. (VRX.N)

Latest Forecast* No. of Yr ago

analysts qtr
Loss, (diluted, $/shr) 0.23 -- -- 0.48
EPS, pre ex#(dil, $/shr) 0.28 -- -- 0.18
Net loss ($ million) 21.8 -- -- 44.8
Revenue ($ million) 257.4 229.9 6 232.2

*Source: Reuters Estimates

#Excludes extraordinary, special or one-time items

--The pharmaceutical company said it recorded a charge of
$5.2 million due to cost of goods sold in the 2006 fourth
quarter for the transfer of manufacturing technology for
Infergen.

--For the latest fourth quarter, analysts on average
expected the company to earn 18 cents a share, excluding
exceptional items, according to Reuters Estimates.
(Reporting by Supantha Mukherjee in Bangalore)